StemCures to inject $54m in India's largest stem cell lab in Telangana

HYDERABAD: US-based StemCures is gearing up to inject $54 million in setting up what is touted as India's largest stem cell manufacturing lab in Telangana. The company will potentially employ around 150 people in a couple of tranches.
The investment was announced by Telangana industries & IT minister KT Rama Rao's office after the minister met StemCures founder Dr Sairam Atluri during the Boston leg of his US tour.
The proposed lab aims to capitalise on the latest technology and expertise from the US to manufacture quality and affordable stem cell products for treating various serious medical conditions.
Stem cells are undifferentiated cells that have the ability to grow into any type of cell. When injected into an injured or diseased area, stem cells can help repair tissue, reduce inflammation, and promote healing. StemCures is currently wrapping up the R&D of a stem cell line at Aspire Bionest in University of Hyderabad and is ready to set up the first phase of its manufacturing lab.
"Stem cell therapy is a promising new treatment for a variety of conditions. I look forward to working with StemCures to make stem cell therapy more accessible to patients in India."
"Setting up an R&D facility was seamless and now we are looking forward to expanding with the manufacturing plant," said Dr Atluri said.
Ohio-based StemCures is an FDA compliant medical clinic that specialises in stem cell therapy, which is a non-surgical, minimally invasive procedure that uses the patient's own stem cells to treat a variety of conditions.